Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
3101
DELISTED
LHC Group LLC
LHCG
| $858K | ﹤0.01% |
12,098
-5,235
| -30% | -$336K |
|
3102
STAG Industrial
STAG
$7.19B
| $857K | ﹤0.01% |
31,238
-275
| -0.9% | -$7.61K |
|
3103
CALL
iShares MSCI Turkey ETF
TUR
$213M
| $857K | ﹤0.01% |
20,500
+600
| +3% | +$26.4K |
|
3104
Cameco
CCJ
$41.1B
| $856K | ﹤0.01% |
88,445
-467,410
| -84% | -$4.64M |
|
3105
PUT
F5
FFIV
$23.4B
| $856K | ﹤0.01% |
7,100
-3,800
| -35% | -$459K |
|
3106
PUT
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.86B
| $854K | ﹤0.01% |
26,400
-6,800
| -20% | -$213K |
|
3107
CALL
Fortinet
FTNT
$120B
| $853K | ﹤0.01% |
119,000
+2,500
| +2% | +$19K |
|
|
3108
PUT
Fortinet
FTNT
$120B
| $853K | ﹤0.01% |
119,000
+500
| +0.4% | +$3.8K |
|
3109
Hubbell
HUBB
$27.1B
| $853K | ﹤0.01% |
7,365
-11,311
| -61% | -$1.3M |
|
3110
Selective Insurance
SIGI
$5.76B
| $853K | ﹤0.01% |
15,835
+2,800
| +21% | +$142K |
|
3111
PUT
Dine Brands
DIN
$453M
| $851K | ﹤0.01% |
19,800
+18,000
| +1,000% | +$736K |
|
|
RPXC
3112
DELISTED
RPX Corporation
RPXC
| $851K | ﹤0.01% |
64,132
-22,068
| -26% | -$290K |
|
3113
Nutanix
NTNX
$16.5B
| $850K | ﹤0.01% |
37,922
-49,612
| -57% | -$1.09M |
|
3114
Wipro
WIT
$19.8B
| $849K | ﹤0.01% |
398,184
-397,027
| -50% | -$870K |
|
3115
PUT
FMC
FMC
$1.35B
| $848K | ﹤0.01% |
10,954
+6,573
| +150% | +$472K |
|
3116
CALL
New Oriental
EDU
$9.06B
| $847K | ﹤0.01% |
9,600
+6,800
| +243% | +$554K |
|
3117
PUT
ServiceNow
NOW
$121B
| $846K | ﹤0.01% |
36,000
-68,500
| -66% | -$1.52M |
|
3118
First Bancorp
FBP
$4.44B
| $845K | ﹤0.01% |
165,010
+125,177
| +314% | +$714K |
|
3119
Encompass Health
EHC
$11B
| $843K | ﹤0.01% |
22,860
-718
| -3% | -$25.6K |
|
|
LUMO
3120
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $843K | ﹤0.01% |
9,202
+5,046
| +121% | +$387K |
|
3121
CALL
VeriSign
VRSN
$26.5B
| $840K | ﹤0.01% |
7,900
-300
| -4% | -$30.2K |
|
3122
PUT
MPLX
MPLX
$60.1B
| $839K | ﹤0.01% |
23,954
-20,800
| -46% | -$719K |
|
3123
PUT
Murphy Oil
MUR
$5.17B
| $839K | ﹤0.01% |
31,600
+20,500
| +185% | +$514K |
|
|
DNKN
3124
PUT
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $839K | ﹤0.01% |
15,800
-23,000
| -59% | -$1.22M |
|
|
FSP
3125
Franklin Street Properties
FSP
$48M
| $838K | ﹤0.01% |
78,895
-10,002
| -11% | -$103K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.